CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Clinuvel Pharmaceuticals Limited - ADR Company Snapshot
Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other companies in this sector in the United States: Kalvista Pharmaceuticals Inc (2019 sales of $16.13 million of which 100% was Pharmaceuticals), Pharmaxis Ltd ($8.97 million of which 48% was New Drug Development), and Mesoblast Ltd ($16.72 million of which 100% was Mesenchymal Precursor Cell).

Sales Analysis. During the year ended June of 2019, sales at Clinuvel Pharmaceuticals Limited were $22.59 million. This is an increase of 13.4% versus 2018, when the company's sales were $19.92 million. This was the fifth consecutive year of sales increases at Clinuvel Pharmaceuticals Limited (and since 2014, sales have increased a total of 727%).
   
   
 
  Stock Performance Chart for Clinuvel Pharmaceuticals Limited - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 18.21
(Figures in U.S. Dollars)
1 Week -3.0%   13 Weeks -12.7%  
4 Weeks -1.9%   52 Weeks 48.8%  
 
Clinuvel Pharmaceuticals Limited - ADR Key Data:
  Ticker: CLVLY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 22,593,722
(Year Ending Jan 2020).
Employees: 16
  Currency: U.S. Dollars Market Cap: 891,573,127
  Fiscal Yr Ends: June Shares Outstanding: 48,960,633
  Share Type: Ordinary Closely Held Shares: 11,573,459
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.